AmCad BioMed Corp Sustainability Reports

AmCad BioMed Corporation develops and manufactures artificial intelligence-powered medical diagnostic software devices. Its solutions use advanced ultrasound image analysis to assist medical professionals in detecting thyroid cancer, obstructive sleep apnea, and liver conditions.

Sector: Manufacturing

Country: Taiwan

Exchange: Taipei Exchange

FIGI: BBG005Q5BB10

3 reports from 2024 to 2025

• AmCad BioMed Corp 2025 Parent Company Only Financial Statements with Report of Independent Auditors
• AmCad BioMed Corp 2024 Sustainability Report
• AmCad BioMed Corp 2024 Parent Company Only Financial Statements With Report of Independent Auditors